The Patent Finder

Senex Biotechnology, Inc.

Also on record
Records under this name other than the patents Senex Biotechnology, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 4 patents it holds.

Showing 1 to 5 of 5 · Back to Senex Biotechnology, Inc.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 11,014,906Quinoline-Based Compounds and Methods of Inhibiting CDK8/19
Formerly held
In force
 · High confidence
In forceHigh confidence
US 12,281,080Quinoline-Based Compounds and Methods of Inhibiting CDK8/19
Formerly held
In force
 · High confidence
In forceHigh confidence
US 11,572,369Bicyclic Pyridine Compositions and Methods of Using the Same for Cancer Therapy
Formerly held
In force
 · High confidence
In forceHigh confidence
US 10,584,369Cell-based methods for measuring activity of a protein inhibitor
Lapsed on the fee record
Ended Mar 10, 2024 · USPTO record
Lapsed on the fee recordEnded Mar 10, 2024USPTO record
US 8,592,147High-content screening for drugs against cancer and age-related diseases
Lapsed on the fee record
Ended Nov 26, 2021 · USPTO record
Lapsed on the fee recordEnded Nov 26, 2021USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited